Full text is available at the source.
Abstract
12-month adherence patterns for glucagon-like peptide-1 receptor agonists may vary among adults and pediatric patients with obesity without diabetes.
- Adherence to GLP-1 receptor agonists is underexplored in individuals without diabetes and children.
- Identifying adherence trajectories can help understand treatment patterns in this population.
- Factors influencing adherence may include specific characteristics of the patients.
- The study focuses on real-world usage rather than controlled clinical settings.
Simplified